TVARDI THERAPEUTICS, INC. Accumulated Amortization, Debt Issuance Costs
TVARDI THERAPEUTICS, INC. (TVRD) had Accumulated Amortization, Debt Issuance Costs of $117.00 thousand as of 2013-12-31, per its 10-K filed 2016-03-11.
Discontinued › Notes
us-gaap:AccumulatedAmortizationDeferredFinanceCosts · last filed 2016-03-11
- 2013-12-31: Accumulated Amortization, Debt Issuance Costs $117.00K.
- 2012-12-31: Accumulated Amortization, Debt Issuance Costs $4.00K.
| Period end | Accumulated Amortization, Debt Issuance Costs |
|---|---|
| 2013-12-31 | $117.00K 10-K · filed 2016-03-11 |
| 2012-12-31 | $4.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |